MCP AbD Serotec
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on June 1, 2008.
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M700483-MCP200v1
7/6/1174    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tan, H. T.
Right arrow Articles by Chung, M. C.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tan, H. T.
Right arrow Articles by Chung, M. C.M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on October 5, 2007
Revised on March 3, 2008
Accepted on March 14, 2008

Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells

Hwee Tong Tan, Sandra Tan, Qingsong Lin, Teck Kwang Lim, Choy Leong Hew, and Maxey C.M. Chung

Biochemistry, National University of Singapore, Singapore 117597

Corresponding Author: bchcm{at}nus.edu.sg

Colorectal cancer is one of the most common cancers in developed countries, and its incidence is negatively associated with high dietary fiber intake. Butyrate, a short-chain fatty acid fermentation by-product of fiber induces cell maturation with the promotion of growth arrest, differentiation, and/or apoptosis of cancer cells. The stimulation of cell maturation by butyrate in colonic cancer cells follows a temporal progression, from the early phase of growth arrest to the activation of apoptotic cascades. Previously, we performed 2-D DIGE to identify differentially expressed proteins induced by 24h butyrate treatment of HCT-116 colorectal cancer cells. Herein, we employed quantitative proteomics approaches using iTRAQ, a stable isotope labeling methodology that enables multiplexing of 4 samples, for a temporal study of HCT-116 cells treated with butyrate. In addition, cICAT which selectively tags cysteine-containing proteins was also used, and the results complemented that obtained from the iTRAQ strategy. Selected protein targets were validated by real-time PCR and western blotting. A model is proposed to illustrate our findings from this temporal analysis of butyrate-responsive proteome which uncovered several integrated cellular processes and pathways involved in growth arrest, apoptosis, and metastasis. These signature clusters of butyrate-regulated pathways are potential targets for novel chemopreventive and therapeutic drugs for treatment of colorectal cancer.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.